- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 3.45 Å
- Oligo State
- hetero-oligomer
- Ligands
- 2 x STU: STAUROSPORINE(Non-covalent)
- 2 x 85V: 1,4:3,6-dianhydro-2-O-(6-chloro-5-{4-[1-(hydroxymethyl)cyclopropyl]phenyl}-1H-benzimidazol-2-yl)-D-mannitol(Non-covalent)
85V.2: 20 residues within 4Å:- Chain A: V.13, L.20, G.21, F.29, G.30, K.31, K.33, I.48, L.49, N.50, K.53, D.90, F.92
- Chain B: V.15, R.17, T.40, D.42, V.47, I.49
- Chain D: D.219
15 PLIP interactions:10 interactions with chain A, 5 interactions with chain B- Hydrophobic interactions: A:V.13, A:L.20, A:K.33, A:I.48, B:T.40, B:D.42, B:V.47, B:V.47
- Hydrogen bonds: A:G.21, A:F.29, A:K.31, A:N.50, A:N.50
- pi-Cation interactions: A:K.33, B:R.17
85V.12: 20 residues within 4Å:- Chain A: D.219
- Chain D: V.13, L.20, G.21, F.29, G.30, K.31, K.33, I.48, L.49, N.50, K.53, D.90, F.92
- Chain E: V.15, R.17, T.40, D.42, V.47, I.49
15 PLIP interactions:10 interactions with chain D, 5 interactions with chain E- Hydrophobic interactions: D:V.13, D:L.20, D:K.33, D:I.48, E:T.40, E:D.42, E:V.47, E:V.47
- Hydrogen bonds: D:G.21, D:F.29, D:K.31, D:N.50, D:N.50
- pi-Cation interactions: D:K.33, E:R.17
- 6 x CL: CHLORIDE ION(Non-functional Binders)
CL.3: 2 residues within 4Å:- Chain A: S.99, A.151
Ligand excluded by PLIPCL.4: 1 residues within 4Å:- Chain A: V.26
Ligand excluded by PLIPCL.5: 3 residues within 4Å:- Chain A: F.104, I.107, G.212
Ligand excluded by PLIPCL.13: 2 residues within 4Å:- Chain D: S.99, A.151
Ligand excluded by PLIPCL.14: 1 residues within 4Å:- Chain D: V.26
Ligand excluded by PLIPCL.15: 3 residues within 4Å:- Chain D: F.104, I.107, G.212
Ligand excluded by PLIP- 4 x SO4: SULFATE ION(Non-functional Binders)
SO4.6: 2 residues within 4Å:- Chain A: K.36, K.43
2 PLIP interactions:2 interactions with chain A- Salt bridges: A:K.36, A:K.43
SO4.10: 4 residues within 4Å:- Chain C: R.151, T.167, K.169, H.297
2 PLIP interactions:2 interactions with chain C- Salt bridges: C:R.151, C:H.297
SO4.16: 2 residues within 4Å:- Chain D: K.36, K.43
2 PLIP interactions:2 interactions with chain D- Salt bridges: D:K.36, D:K.43
SO4.20: 4 residues within 4Å:- Chain F: R.151, T.167, K.169, H.297
3 PLIP interactions:3 interactions with chain F- Hydrogen bonds: F:T.167
- Salt bridges: F:R.151, F:H.297
- 4 x AMP: ADENOSINE MONOPHOSPHATE(Non-covalent)
AMP.7: 13 residues within 4Å:- Chain C: H.150, T.199, N.202, I.203, A.204, V.224, S.225, A.226, P.228, I.311, S.313, S.315, D.316
11 PLIP interactions:11 interactions with chain C- Hydrogen bonds: C:T.199, C:T.199, C:A.204, C:A.204, C:S.225, C:S.225, C:S.225, C:S.313, C:S.315, C:D.316
- Salt bridges: C:H.150
AMP.8: 12 residues within 4Å:- Chain C: R.69, I.239, S.241, F.243, D.244, R.268, G.274, V.275, L.276, V.296, H.297, R.298
10 PLIP interactions:10 interactions with chain C- Hydrogen bonds: C:S.241, C:D.244, C:R.268, C:L.276, C:L.276, C:H.297, C:R.298
- Salt bridges: C:R.69, C:H.297, C:R.298
AMP.17: 13 residues within 4Å:- Chain F: H.150, T.199, N.202, I.203, A.204, V.224, S.225, A.226, P.228, I.311, S.313, S.315, D.316
11 PLIP interactions:11 interactions with chain F- Hydrogen bonds: F:T.199, F:T.199, F:A.204, F:A.204, F:S.225, F:S.225, F:S.225, F:S.313, F:S.315, F:D.316
- Salt bridges: F:H.150
AMP.18: 12 residues within 4Å:- Chain F: R.69, I.239, S.241, F.243, D.244, R.268, G.274, V.275, L.276, V.296, H.297, R.298
10 PLIP interactions:10 interactions with chain F- Hydrogen bonds: F:S.241, F:D.244, F:R.268, F:L.276, F:L.276, F:H.297, F:R.298
- Salt bridges: F:R.69, F:H.297, F:R.298
- 2 x ADP: ADENOSINE-5'-DIPHOSPHATE(Non-covalent)
ADP.9: 14 residues within 4Å:- Chain C: R.69, M.84, T.86, I.87, T.88, D.89, Y.120, P.127, L.128, V.129, I.149, H.150, R.151, P.153
13 PLIP interactions:13 interactions with chain C- Hydrogen bonds: C:I.87, C:T.88, C:D.89, C:Y.120, C:Y.120, C:V.129, C:H.150, C:R.151, C:R.151
- Salt bridges: C:R.69, C:H.150, C:H.150, C:R.151
ADP.19: 14 residues within 4Å:- Chain F: R.69, M.84, T.86, I.87, T.88, D.89, Y.120, P.127, L.128, V.129, I.149, H.150, R.151, P.153
13 PLIP interactions:13 interactions with chain F- Hydrogen bonds: F:T.86, F:I.87, F:T.88, F:D.89, F:Y.120, F:V.129, F:H.150, F:R.151, F:R.151
- Salt bridges: F:R.69, F:H.150, F:H.150, F:R.151
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Cokorinos, E.C. et al., Activation of Skeletal Muscle AMPK Promotes Glucose Disposal and Glucose Lowering in Non-human Primates and Mice. Cell Metab. (2017)
- Release Date
- 2017-05-17
- Peptides
- 5'-AMP-activated protein kinase catalytic subunit alpha-1: AD
5'-AMP-activated protein kinase subunit beta-1: BE
5'-AMP-activated protein kinase subunit gamma-1: CF - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AD
AB
BE
BC
CF
C
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 3.45 Å
- Oligo State
- hetero-oligomer
- Ligands
- 2 x STU: STAUROSPORINE(Non-covalent)
- 2 x 85V: 1,4:3,6-dianhydro-2-O-(6-chloro-5-{4-[1-(hydroxymethyl)cyclopropyl]phenyl}-1H-benzimidazol-2-yl)-D-mannitol(Non-covalent)
- 6 x CL: CHLORIDE ION(Non-functional Binders)
- 4 x SO4: SULFATE ION(Non-functional Binders)
- 4 x AMP: ADENOSINE MONOPHOSPHATE(Non-covalent)
- 2 x ADP: ADENOSINE-5'-DIPHOSPHATE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Cokorinos, E.C. et al., Activation of Skeletal Muscle AMPK Promotes Glucose Disposal and Glucose Lowering in Non-human Primates and Mice. Cell Metab. (2017)
- Release Date
- 2017-05-17
- Peptides
- 5'-AMP-activated protein kinase catalytic subunit alpha-1: AD
5'-AMP-activated protein kinase subunit beta-1: BE
5'-AMP-activated protein kinase subunit gamma-1: CF - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AD
AB
BE
BC
CF
C